VST reports Wednesday after a month that saw the stock climb 7.6% to $164.35, even as options positioning turned sharply more cautious. The put/call ratio hit 1.57, running well above its recent average and marking one of the most defensive setups in a year. Short interest has eased to 2.7% of the float, down nearly 5% over the month. Borrow costs remain trivial at 0.36%, and utilisation sits at just 0.38% — nowhere near the 4% peak hit last year. The setup looks more like investor profit-taking than building conviction in either direction.
The Street still sees meaningful upside from current levels, with a consensus target around $233 implying roughly 42% return potential. Recent activity has been mixed but generally constructive. JPMorgan nudged its target to $240 in mid-March while holding an Overweight rating. Wells Fargo trimmed slightly to $234 post the February print but kept its bullish stance. The most notable move came in February when Jefferies upgraded to Buy and lifted its target to $203, signaling a shift in sentiment after prior caution. BofA and BMO have both adjusted targets in recent months, though all remain materially above the current price.
Bulls point to the company's improved operational efficiency and cash flow trajectory, targeting free cash flow conversion above 60% of adjusted EBITDA starting this year. The Cogentrix acquisition added generation capacity, and retail margins have benefited from effective hedging. Valuation multiples have compressed slightly — the EV/EBITDA ratio fell to 10.2 from 10.4 a month ago — but the stock still trades at 17.6 times earnings, up from 16.9 a month prior. Bears cite the 30% pullback from recent highs despite positive catalysts, ongoing margin pressure from commodity volatility, and an estimated $1.6 billion adverse EBITDA impact from fuel and procurement costs. The company has consistently beaten estimates, ranking in the 96th percentile on EPS surprise, yet recent earnings reactions have been negative — the stock fell an average of 4% over five days following the last three prints.
Insider activity has been one-sided, with net selling of 1.3 million shares totaling $223 million over the past 90 days. CEO James Burke and CFO Kris Moldovan led the selling in late February and early March. Major institutions have been adding — Vanguard, BlackRock, and State Street all increased holdings in Q1. The earnings report will test whether the company can deliver on its free cash flow promises and retail margin expansion, or whether the commodity headwinds and margin pressure that spooked the market earlier this year remain the dominant narrative.
See the live data behind this article on ORTEX.
Open VST on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
